Profilo
Dr. Ivo Staijen is a Head Public Equity & Portfolio Manager at HBM Partners AG.
He has over 15 years of experience in the pharma industry and investment analysis and portfolio management.
He was previously a Senior Biotechnology Analyst at Bank Sarasin and Department Head at MDS Pharma Services.
He holds a Ph.D.
in biotechnology from ETH Zurich and an M.Sc.
in chemistry from the University of Groningen.
Posizioni attive di Ivo Staijen
| Società | Posizione | Inizio |
|---|---|---|
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs. | Head-Equity Investments | 01/04/2003 |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Investitore di Private Equity | 01/04/2003 |
Precedenti posizioni note di Ivo Staijen
| Società | Posizione | Fine |
|---|---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Direttore/Membro del Consiglio | 03/10/2012 |
Bank Sarasin & Cie AG (Broker)
Bank Sarasin & Cie AG (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 06/02/2003 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Health Technology |
Bank Sarasin & Cie AG (Broker)
Bank Sarasin & Cie AG (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs. | Finance |
















